Surviving Benzodiazepines: A Patient’s and Clinician’s Perspectives Carrie M. SilvernailSteven L. Wright Commentary Open access 03 March 2022 Pages: 1871 - 1880
P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease Robert A. HauserNir GiladiPninit Litman Commentary Open access 10 March 2022 Pages: 1881 - 1894
New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management Dave SinghGabriel GarciaNorbert Berend Review Open access 14 March 2022 Pages: 1895 - 1914
Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy Min YangHiroyuki AwanoAtaru Igarashi Review Open access 20 March 2022 Pages: 1915 - 1958
Literature Review of Fatigue Scales and Association with Clinically Meaningful Improvements in Outcomes Among Patients With and Without Paroxysmal Nocturnal Hemoglobinuria Sangeeta KrishnanSujata SardaCarmelita P. Escalante Review Open access 22 March 2022 Pages: 1959 - 1975
Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis Thierry FaconJesús San-MiguelShaji Kumar Original Research Open access 05 March 2022 Pages: 1976 - 1992
Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis Ismaeel YunusaNazia RashidKrithika Rajagopalan Original Research Open access 05 March 2022 Pages: 1993 - 2008
Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease Avner ThalerYael BarerTanya Gurevich Original Research Open access 05 March 2022 Pages: 2009 - 2024
A Double-Blind, Placebo-Controlled Study of Appropriate Site of Botulinum Toxin Therapy in Hemifacial Spasm Suthipun JitpimolmardBandit ThinkhamropKittisak Sawanyawisuth Original Research 10 March 2022 Pages: 2025 - 2034
Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life Ion AgirrezabalVictoria K. BrennanValérie Vilgrain Original Research Open access 12 March 2022 Pages: 2035 - 2051
Prescription Market Share and Treatment Patterns in Atopic Dermatitis: A Retrospective Observational Study Using US Insurance Claims Christian FenskeNatalie BoytsovZach Dawson Original Research Open access 14 March 2022 Pages: 2052 - 2064
Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab Andrew Menzies-GowFlavia L. HoyteRohit Katial Original Research Open access 14 March 2022 Pages: 2065 - 2084
Efficacy and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution: A Retrospective Analysis of Real-World Data in Japan Atsuya MikiEtsuyo MiyamotoLESPOIR Research Group Original Research Open access 14 March 2022 Pages: 2085 - 2095
Advantages in Management and Remote Monitoring of Intravenous Therapy: Exploratory Survey and Economic Evaluation of Gravity-Based Infusions in Finland Antti PuolitaivalMikko SavolaErkki Soini Original Research Open access 14 March 2022 Pages: 2096 - 2108
Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study) Bincy AbrahamBertus EksteenArif Soonasra Original Research Open access 16 March 2022 Pages: 2109 - 2127
Superior Bioavailability of a Novel Curcumin Formulation in Healthy Humans Under Fasting Conditions Sudhakar KothapllyShankar AlukapallyRambabu Maddela Original Research Open access 16 March 2022 Pages: 2128 - 2138
Polytrauma in the Geriatric Population: Analysis of Outcomes for Surgically Treated Multiple Fractures with a Minimum 2 Years of Follow-Up Orcun Sahin Original Research 16 March 2022 Pages: 2139 - 2150
Mepivacaine Versus Bupivacaine for Spinal Anesthesia: A Systematic Review and Meta-analysis of Random Controlled Trials Haifeng TanTeng WanYu Xie Original Research 16 March 2022 Pages: 2151 - 2164
Economic Evaluation of Sintilimab Plus Bevacizumab Versus Sorafenib as a First-line Treatment for Unresectable Hepatocellular Carcinoma Ting ZhouYingdan CaoHongchao Li Original Research 16 March 2022 Pages: 2165 - 2177
Opioid-Induced Constipation: Cost Impact of Approved Medications in the Emergency Department W. Frank PeacockNeal SlatkinGeorge Joseph Original Research Open access 17 March 2022 Pages: 2178 - 2191
The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study Sandro GentileGiuseppina GuarinoNefrocenter and Nyx Start-up, AMDOSDI Study Group on Injection Techniques, and ANIAD Original Research Open access 19 March 2022 Pages: 2192 - 2207
The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study Kristina S. BoyeVivian T. ThieuRosirene Paczkowski Original Research Open access 22 March 2022 Pages: 2208 - 2221
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases Masataka KuwanaAiko SaitoKumiko Saito Original Research Open access 22 March 2022 Pages: 2222 - 2235
Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan Andrea LeithJeri KimSameer R. Ghate Original Research Open access 22 March 2022 Pages: 2236 - 2255
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis Craig L. LeonardiKyoungah SeeRichard B. Warren Original Research Open access 22 March 2022 Pages: 2256 - 2269
Environmental Sustainability in Respiratory Care: An Overview of the healthCARe-Based envirONmental Cost of Treatment (CARBON) Programme Alex WilkinsonEkaterina MaslovaMichael G. Crooks Study Protocol Open access 13 March 2022 Pages: 2270 - 2280
Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era Stefan SchreiberShomron Ben-HorinWalter Reinisch Correction 14 March 2022 Pages: 2281 - 2281